The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients
Open accessAbstract
The clinical profile of belatacept in kidney transplant recipients was evaluated to determine if earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 year, phase III study in adults receiving a kidney transplant from a living or standard criteria deceased donor. Patients were randomized to a more (MI) or less intensive (LI) regimen of belatacept, or cyclosporine. 471/666 patients completed ≥3 years of therapy. A total of 92% (MI), 92% (LI), and 89% (cyclosporine) of patients survived with a functioning graft. The mean calculated GFR (cGFR) was ∼21 mL/min/1.73 m(2) higher in the belatacept groups versus cyclosporine at year 3. From month 3 to month 36, the mean cGFR increased in the belatacept groups by +1.0 mL/min/1.73 m(2) /year (MI) and +1.2 mL/min/1.73 m(2) /year (LI) versus a decline of -2.0 mL/min/1.73 m(2) /year (cyclosporine). One cyclosporine-treated patient experienced acute rejection between year 2 and year 3. There were no new safety signals and no new posttransplant lymphoproliferative disorder (PTLD) cases after month 18. Belatacept-treated patients maintained a high rate of patient and graft survival that was comparable to cyclosporine-treated patients, despite an early increased occurrence of acute rejection and PTLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
The Natural History of Chronic Allograft Nephropathy
Nankivell, B. J., Borrows, R. J., Fung, C. L.-S., O'Connell, P. J., Allen, R. D. M., & Chapman, J. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020009 · Cited by 1,949
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
Ekberg, H., Tedesco-Silva, H., Demirbas, A., Vítko, Š., Nashan, B., Gürkan, A., Margreiter, R., Hugo, C., Grinyó, J. M., Frei, U., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067411 · Cited by 1,810
Calcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
Vincenti, F., Charpentier, B., Vanrenterghem, Y., Rostaing, L., Bresnahan, B., Darji, P., Massari, P., Mondragon‐Ramirez, G. A., Agarwal, M., Di Russo, G., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.03005.x · Cited by 957
Self-citationPost-transplant renal function in the first year predicts long-term kidney transplant survival
Hariharan, S., Mcbride, M. A., Cherikh, W. S., Tolleris, C. B., Bresnahan, B. A., & Johnson, C. P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00424.x · Cited by 748
Self-citationLarsen, C. P., Pearson, T. C., Adams, A. B., Tso, P., Shirasugi, N., Strobertb, E., Anderson, D., Cowan, S., Price, K., Naemura, J., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00749.x · Cited by 723
Self-citationDurrbach, A., Pestana, J. M., Pearson, T., Vincenti, F., Garcia, V. D., Campistol, J., Del Carmen Rial, M., Florman, S., Block, A., Di Russo, G., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03016.x · Cited by 570
Self-citationEkberg, H., Bernasconi, C., Tedesco-Silva, H., Vítko, S., Hugo, C., Demirbas, A., Reyes Acevedo, R., Grinyó, J., Frei, U., Vanrenterghem, Y., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02726.x · Cited by 334
Self-citationTransplant Outcomes and Economic Costs Associated with Patient Noncompliance to Immunosuppression
Pinsky, B. W., Takemoto, S. K., Lentine, K. L., Burroughs, T. E., Schnitzler, M. A., & Salvalaggio, P. R. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02798.x · Cited by 331
Meier-Kriesche, H.-U., Baliga, R., & Kaplan, B. (2003) · Transplantation · doi:10.1097/01.tp.0000061602.03327.e2 · Cited by 327
Larson, T. S., Dean, P. G., Stegall, M. D., Griffin, M. D., Textor, S. C., Schwab, T. R., Gloor, J. M., Cosio, F. G., Lund, W. J., Kremers, W. K., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01177.x · Cited by 299
Lebranchu, Y., Thierry, A., Toupance, O., Westeel, P. F., Etienne, I., Thervet, E., Moulin, B., Frouget, T., Le Meur, Y., Glotz, D., et al. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02615.x · Cited by 263
Long-Term Benefits with Sirolimus-Based Therapy after Early Cyclosporine Withdrawal
Kreis, H., Oberbauer, R., Campistol, J. M., Mathew, T., Daloze, P., Schena, F. P., Burke, J. T., Brault, Y., Gioud-Paquet, M., Scarola, J. A., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113248.59077.76 · Cited by 225
Rao, P. S., Schaubel, D. E., Jia, X., Li, S., Port, F. K., & Saran, R. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.11.022 · Cited by 213
Five-Year Safety and Efficacy of Belatacept in Renal Transplantation
Vincenti, F., Blancho, G., Durrbach, A., Friend, P., Grinyo, J., Halloran, P. F., Klempnauer, J., Lang, P., Larsen, C. P., Mühlbacher, F., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009111109 · Cited by 189
Self-citationLarsen, C. P., Grinyó, J., Medina-Pestana, J., Vanrenterghem, Y., Vincenti, F., Breshahan, B., Campistol, J. M., Florman, S., Rial, M. D. C., Kamar, N., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181ff87cd · Cited by 173
Self-citationBüchler, M., Caillard, S., Barbier, S., Thervet, E., Toupance, O., Mazouz, H., Hurault de Ligny, B., Le Meur, Y., Thierry, A., Villemain, F., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01976.x · Cited by 169
Lymphoproliferative Disease after Renal Transplantation in Australia and New Zealand
Faull, R., HOLLETT, P. R., & McDonald, S. P. (2005) · Transplantation · doi:10.1097/01.tp.0000165098.49658.f3 · Cited by 138
Fellström, B., Jardine, A. G., Soveri, I., Cole, E., Neumayer, H., Maes, B., Gimpelewicz, C. R., & Holdaas, H. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00983.x · Cited by 117
Opelz, G., & Döhler, B. (2009) · Transplantation · doi:10.1097/tp.0b013e318199c1c7 · Cited by 116
The Change in Allograft Function among Long-Term Kidney Transplant Recipients
Gill, J. S., Tonelli, M. A., Mix, C. H., & Pereira, B. J. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070621.06264.86 · Cited by 106
An Integrated View of Molecular Changes, Histopathology and Outcomes in Kidney Transplants
Halloran, P. F., de Freitas, D. G., Einecke, G., Famulski, K. S., Hidalgo, L. G., Mengel, M., REEVE, J. P., Sellarés, J., & Sis, B. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03268.x · Cited by 94
Gera, M., Slezak, J. M., Rule, A. H., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01690.x · Cited by 81
Long-term graft function changes in kidney transplant recipients
Marcén, R., Morales, J. M., Fernandez-Rodriguez, A., Capdevila, L., Pallardó, L., Plaza, J. J. G., Cubero, J. J., Puig, J. M., Sánchez-Fructuoso, A. I., Arias, M., et al. (2010) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfq063 · Cited by 69
Fellstr�m, B. C., Jardine, A. G., Soveri, I., Cole, E., nhagen-Riska, C. G., Neumayer, H. H., Maes, B., Gimpelewicz, C. R., & Holdaas, H. (2005) · Transplantation · doi:10.1097/01.tp.0000160764.35083.b8 · Cited by 61
Treatment Adherence in Renal Transplant Recipients: A Questionnaire Survey on Immunosuppressants
Ichimaru, N., Kakuta, Y., Abe, T., Okumi, M., Imamura, R., Isaka, Y., Nonomura, N., Kojima, Y., Okuyama, Ä., & Takahara, S. (2008) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.02.083 · Cited by 53
Srinivas, T. R., Flechner, S. M., Poggio, E. D., Askar, M. Z., Goldfarb, D. A., Navaneethan, S. D., & Schold, J. D. (2010) · Transplantation · doi:10.1097/tp.0b013e3182003dda · Cited by 28
Cited by
CD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
Belatacept and Long-Term Outcomes in Kidney Transplantation
Vincenti, F., Rostaing, L., Grinyo, J., Rice, K., Steinberg, S., Gaite, L., Moal, M.-C., Mondragon-Ramirez, G. A., Kothari, J., Polinsky, M. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506027 · Cited by 783
Self-citationAllen, U. D., Preiksaitis, J. K., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13652 · Cited by 375
Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches
Djamali, A., Kaufman, D. B., Ellis, T. M., Zhong, W., Matas, A., & Samaniego, M. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12589 · Cited by 369
Jordan, S. C., Choi, J., Kim, I., Wu, G., Toyoda, M., Shin, B., & Vo, A. (2017) · Transplantation · doi:10.1097/tp.0000000000001452 · Cited by 260
Metadata
- Authors
- Vincenti, F., Larsen, C. P., Alberu, J., Bresnahan, B., Garcia, V. D., Kothari, J., Lang, P., Urrea, E. M., Massari, P., Mondragon-Ramirez, G., Reyes-Acevedo, R., Rice, K., Rostaing, L., Steinberg, S., Xing, J., Agarwal, M., Harler, M. B., & Charpentier, B.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 12
- Issue
- 1
- Pages
- 210-217
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W1480967779
- Cited by
- 313
- References
- 29
- FWCI
- 23.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.